Presentation TCT 2013 TCT-3. Outcomes in STEMI patients treated with clopidogrel or prasugrel: A propensity adjusted analysis from the INFUSE-AMI Trial Presenter: Keith Oldroyd October 29, 2013 REGISTER for free or LOG IN to view this content CAD Pharma Presentation TCT 2013 Up Next Presentation TCT 2013 PCI vs. CABG in Multivessel Disease: Integrating Evidence-Based Medicine with Today's Techniques and Devices for Appropriate Decision Making Presenter: Marie-Claude Morice October 29, 2013 More slides + Presentation TCT 2013 TCT-83. Risk Model for Estimating the One-Year Risk of Deferred Lesion Intervention Following Deferred Revascularization after Fractional Flow Reserve Assessment Presenter: Jeremiah Depta October 29, 2013 Presentation TCT 2013 Does GDMT Reduce Ischemia and/or Prevent Death and/or MI in SIHD? Presenter: Leslee Shaw October 29, 2013 We Recommend
Presentation TCT 2013 PCI vs. CABG in Multivessel Disease: Integrating Evidence-Based Medicine with Today's Techniques and Devices for Appropriate Decision Making Presenter: Marie-Claude Morice October 29, 2013
Presentation TCT 2013 TCT-83. Risk Model for Estimating the One-Year Risk of Deferred Lesion Intervention Following Deferred Revascularization after Fractional Flow Reserve Assessment Presenter: Jeremiah Depta October 29, 2013
Presentation TCT 2013 Does GDMT Reduce Ischemia and/or Prevent Death and/or MI in SIHD? Presenter: Leslee Shaw October 29, 2013